Specialty Pharmacy

Prescription drug spending expected to increase from 2017 to 2025 due to costly specialty drugs.

Patients who experienced side effects were 3 times more likely not to meet LDL cholesterol targets.

Cannabidiol found in cannabis could be used as a novel treatment for hepatitis C virus

Top news of the week from Specialty Pharmacy Times.

Cancer cells adjusted to have normal circadian rhythm slowed tumor growth.

The Iowa Department of Public Health released its first report on hepatitis C virus.

Extrachromosomal oncogene helps drive tumor evolution and heterogeneity.

Statins among promising treatment options helping to progress the HIV treatment landscape.

Central nervous system lesions may impede cognitive and sensorimotor function in patients with MS.

Lenalidomide (Revlimid) maintenance improved survival in multiple myeloma patients following a stem cell transplant.

Treatment with omega-3 reduces levels of IgE antibodies to reduce the risk of asthma flare-ups.

Tumors containing JAK1 and JAK2 mutations effect response to immunotherapy in patients with melanoma and colon cancer.

Application filed for ceritinib (Zykadia) as a first-line treatment for patients with metastatic non-small cell lung cancer.

Top news of the day from across the health care landscape.

The second of a 2-part interview with National Association of Specialty Pharmacy President Rebecca Shanahan on the hottest issues in specialty pharmacy.

Physical activity drops during and after cancer treatment.

Potential drug may have a protective role in chronic obstructive pulmonary disease.

Anxiety and depression linked to longer time living with HIV.

Habits such as alcohol use, along with consumption of red meat and processed meat found to influence the risk of cancer.

Extensive psoriasis lesions remained in 18% of patients undergoing treatment.

Top news of the day from across the health care landscape.

Inotuzumab ozogamicin treats relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

From improved adherence to fewer visits to the pharmacy, medication synchronization offers significant benefits for patients.

Over the last few months, new developments have taken place within the biosimilar market including new drug approvals and guidance documents released by the FDA.

MJH Events team to leverage industry expertise of Specialty Pharmacy Times® editorial board in collaboration with NASP Board of Directors to develop industry leading content for September Annual Meeting.

NASP President Rebecca Shanahan discusses pressing topics in specialty pharmacy, including DIR fees and the potential impact of the Trump administration.

Few studies have examined the importance of socioeconomic risk factors on overall health.

New system could improve the implementation of pre-exposure prophylaxis-based care for HIV prevention.